Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer

Chengfei Liu, Wei Lou, Joy C. Yang, Liangren Liu, Cameron M. Armstrong, Alan P. Lombard, Ruining Zhao, Onika D.V. Noel, Clifford G Tepper, Hongwu Chen, Marc Dall'Era, Christopher P Evans, Allen C Gao

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Protein homeostasis (proteostasis) is a potential mechanism that contributes to cancer cell survival and drug resistance. Constitutively active androgen receptor (AR) variants confer anti-androgen resistance in advanced prostate cancer. However, the role of proteostasis involved in next generation anti-androgen resistance and the mechanisms of AR variant regulation are poorly defined. Here we show that the ubiquitin-proteasome-system (UPS) is suppressed in enzalutamide/abiraterone resistant prostate cancer. AR/AR-V7 proteostasis requires the interaction of E3 ubiquitin ligase STUB1 and HSP70 complex. STUB1 disassociates AR/AR-V7 from HSP70, leading to AR/AR-V7 ubiquitination and degradation. Inhibition of HSP70 significantly inhibits prostate tumor growth and improves enzalutamide/abiraterone treatments through AR/AR-V7 suppression. Clinically, HSP70 expression is upregulated and correlated with AR/AR-V7 levels in high Gleason score prostate tumors. Our results reveal a novel mechanism of anti-androgen resistance via UPS alteration which could be targeted through inhibition of HSP70 to reduce AR-V7 expression and overcome resistance to AR-targeted therapies.

Original languageEnglish (US)
Number of pages1
JournalNature Communications
Volume9
Issue number1
DOIs
StatePublished - Nov 16 2018

Fingerprint

Androgen Receptors
therapy
Prostatic Neoplasms
cancer
sensitivity
homeostasis
Therapeutics
Androgens
Homeostasis
Proteasome Endopeptidase Complex
Ubiquitin
proteins
Tumors
Prostate
tumors
Neoplasms
Proteins
Ubiquitin-Protein Ligases
Neoplasm Grading
Ubiquitination

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer. / Liu, Chengfei; Lou, Wei; Yang, Joy C.; Liu, Liangren; Armstrong, Cameron M.; Lombard, Alan P.; Zhao, Ruining; Noel, Onika D.V.; Tepper, Clifford G; Chen, Hongwu; Dall'Era, Marc; Evans, Christopher P; Gao, Allen C.

In: Nature Communications, Vol. 9, No. 1, 16.11.2018.

Research output: Contribution to journalArticle

Liu, Chengfei ; Lou, Wei ; Yang, Joy C. ; Liu, Liangren ; Armstrong, Cameron M. ; Lombard, Alan P. ; Zhao, Ruining ; Noel, Onika D.V. ; Tepper, Clifford G ; Chen, Hongwu ; Dall'Era, Marc ; Evans, Christopher P ; Gao, Allen C. / Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer. In: Nature Communications. 2018 ; Vol. 9, No. 1.
@article{8bd3ed3e95384408af7d06679af0a367,
title = "Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer",
abstract = "Protein homeostasis (proteostasis) is a potential mechanism that contributes to cancer cell survival and drug resistance. Constitutively active androgen receptor (AR) variants confer anti-androgen resistance in advanced prostate cancer. However, the role of proteostasis involved in next generation anti-androgen resistance and the mechanisms of AR variant regulation are poorly defined. Here we show that the ubiquitin-proteasome-system (UPS) is suppressed in enzalutamide/abiraterone resistant prostate cancer. AR/AR-V7 proteostasis requires the interaction of E3 ubiquitin ligase STUB1 and HSP70 complex. STUB1 disassociates AR/AR-V7 from HSP70, leading to AR/AR-V7 ubiquitination and degradation. Inhibition of HSP70 significantly inhibits prostate tumor growth and improves enzalutamide/abiraterone treatments through AR/AR-V7 suppression. Clinically, HSP70 expression is upregulated and correlated with AR/AR-V7 levels in high Gleason score prostate tumors. Our results reveal a novel mechanism of anti-androgen resistance via UPS alteration which could be targeted through inhibition of HSP70 to reduce AR-V7 expression and overcome resistance to AR-targeted therapies.",
author = "Chengfei Liu and Wei Lou and Yang, {Joy C.} and Liangren Liu and Armstrong, {Cameron M.} and Lombard, {Alan P.} and Ruining Zhao and Noel, {Onika D.V.} and Tepper, {Clifford G} and Hongwu Chen and Marc Dall'Era and Evans, {Christopher P} and Gao, {Allen C}",
year = "2018",
month = "11",
day = "16",
doi = "10.1038/s41467-018-07178-x",
language = "English (US)",
volume = "9",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer

AU - Liu, Chengfei

AU - Lou, Wei

AU - Yang, Joy C.

AU - Liu, Liangren

AU - Armstrong, Cameron M.

AU - Lombard, Alan P.

AU - Zhao, Ruining

AU - Noel, Onika D.V.

AU - Tepper, Clifford G

AU - Chen, Hongwu

AU - Dall'Era, Marc

AU - Evans, Christopher P

AU - Gao, Allen C

PY - 2018/11/16

Y1 - 2018/11/16

N2 - Protein homeostasis (proteostasis) is a potential mechanism that contributes to cancer cell survival and drug resistance. Constitutively active androgen receptor (AR) variants confer anti-androgen resistance in advanced prostate cancer. However, the role of proteostasis involved in next generation anti-androgen resistance and the mechanisms of AR variant regulation are poorly defined. Here we show that the ubiquitin-proteasome-system (UPS) is suppressed in enzalutamide/abiraterone resistant prostate cancer. AR/AR-V7 proteostasis requires the interaction of E3 ubiquitin ligase STUB1 and HSP70 complex. STUB1 disassociates AR/AR-V7 from HSP70, leading to AR/AR-V7 ubiquitination and degradation. Inhibition of HSP70 significantly inhibits prostate tumor growth and improves enzalutamide/abiraterone treatments through AR/AR-V7 suppression. Clinically, HSP70 expression is upregulated and correlated with AR/AR-V7 levels in high Gleason score prostate tumors. Our results reveal a novel mechanism of anti-androgen resistance via UPS alteration which could be targeted through inhibition of HSP70 to reduce AR-V7 expression and overcome resistance to AR-targeted therapies.

AB - Protein homeostasis (proteostasis) is a potential mechanism that contributes to cancer cell survival and drug resistance. Constitutively active androgen receptor (AR) variants confer anti-androgen resistance in advanced prostate cancer. However, the role of proteostasis involved in next generation anti-androgen resistance and the mechanisms of AR variant regulation are poorly defined. Here we show that the ubiquitin-proteasome-system (UPS) is suppressed in enzalutamide/abiraterone resistant prostate cancer. AR/AR-V7 proteostasis requires the interaction of E3 ubiquitin ligase STUB1 and HSP70 complex. STUB1 disassociates AR/AR-V7 from HSP70, leading to AR/AR-V7 ubiquitination and degradation. Inhibition of HSP70 significantly inhibits prostate tumor growth and improves enzalutamide/abiraterone treatments through AR/AR-V7 suppression. Clinically, HSP70 expression is upregulated and correlated with AR/AR-V7 levels in high Gleason score prostate tumors. Our results reveal a novel mechanism of anti-androgen resistance via UPS alteration which could be targeted through inhibition of HSP70 to reduce AR-V7 expression and overcome resistance to AR-targeted therapies.

UR - http://www.scopus.com/inward/record.url?scp=85056722973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056722973&partnerID=8YFLogxK

U2 - 10.1038/s41467-018-07178-x

DO - 10.1038/s41467-018-07178-x

M3 - Article

C2 - 30446660

AN - SCOPUS:85056722973

VL - 9

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

ER -